This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

M. J. Friedrich

JAMA. 2000;283:2917-2918.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Charlottesville, Va—In the last few years, the success of highly active antiretroviral therapy (HAART) in suppressing HIV viral load levels has given people infected with HIV hope for survival. Yet while the potent multidrug regimens can prolong life for patients, they have many drawbacks. High costs, adverse effects, toxicity, and a complicated medication schedule often cause noncompliance with or abandonment of treatment. Evidence indicates that HAART cannot completely eliminate HIV from the body, as was once hoped.

But until a way of eradicating the virus is discovered, long-term control of HIV is the goal of therapy. This is why a number of researchers are exploring ways to improve HAART, to minimize its problems without compromising its effectiveness. One approach some are investigating involves prescribing antiretroviral therapy to be given in an intermittent rather than continuous fashion, a method that—if it proves successful—would reduce the amount of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?